Advertisements

Stocking Stuffers

 

Cynapsus Therapeutics Inc. (CTH:CA) Stock Quote

Detailed Quote for Cynapsus Therapeutics Inc. (CTH:CA)
$ N/A N/A (N/A) Volume: 0 N/A
Today 5d 1m 3m 1y more
Last Price
N/A
Change $
N/A
Change %
N/A
Tick
N/A
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
N/A
High
N/A
Low
N/A
Prev Close
N/A
Last Trade
N/A
Volume
0
52 Wk Hi
53.6699981
52 Wk Low
14.00
Market Cap
N/A
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
8,885,944
EPS (TTM)
N/A
PE Ratio
N/A
Exchange
TSX
News and Media for Cynapsus Therapeutics Inc. (CTH:CA)
Sector News | Topic News
News for Cynapsus Therapeutics Inc. (CTH:CA)
Tue, Oct 18, 2016
9:08 AM Cynapsus Therapeutics Obtains Final Court Order and HSR Waiting Period Expires for Plan of Arrangement with Sunovion Pharmaceuticals - GlobeNewswire
Thu, Oct 13, 2016
4:00 PM Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement with Sunovion Pharmaceuticals - GlobeNewswire
Wed, Sep 28, 2016
7:27 PM ISS Recommends Cynapsus Therapeutics Securityholders Vote for the Plan of Arrangement - GlobeNewswire
Wed, Aug 31, 2016
5:07 PM Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics - Business Wire
Mon, Aug 29, 2016
6:01 AM Cynapsus Receives FDA Fast Track Designation for APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease - GlobeNewswire
Mon, Aug 15, 2016
6:00 AM Cynapsus Announces Positive Opinion from Data and Safety Monitoring Board on Phase 3 Parkinson's Disease Clinical Study Allowing for At-Home Titration - GlobeNewswire
Fri, Aug 12, 2016
6:00 AM Cynapsus Announces Publication in the Journal Movement Disorders of Data for the Treatment of OFF Episodes in Patients with Parkinson's Disease - GlobeNewswire
Wed, Aug 10, 2016
4:10 PM Cynapsus Therapeutics Reports Second Quarter 2016 Financial Results and Recent Developments - GlobeNewswire
Mon, Jul 18, 2016
4:10 PM Cynapsus Therapeutics Announces Positive Phase 3 Dose Titration Phase Results with APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease - GlobeNewswire
4:10 PM Cynapsus Therapeutics Provides European Clinical Update for APL-130277 for the Treatment of OFF Episodes in Patients with Parkinson's Disease - GlobeNewswire
Wed, Jul 06, 2016
6:00 AM Cynapsus Therapeutics Announces 2016 Analyst and Investor Day - GlobeNewswire
Thu, Jun 30, 2016
6:00 AM Cynapsus Therapeutics Enrolls Last Patient in Pivotal Phase 3 Efficacy Trial of APL-130277 to Treat OFF Episodes in Patients with Parkinson's Disease - GlobeNewswire
Tue, Jun 21, 2016
6:30 AM Cynapsus Therapeutics Announces Data Presentations at the International Congress of Parkinson's Disease and Movement Disorders - GlobeNewswire
Mon, May 30, 2016
2:03 AM Cynapsus Therapeutics Announces Data Presentations at the European Academy of Neurology Annual Meeting - GlobeNewswire
Fri, May 20, 2016
6:00 AM Cynapsus Therapeutics Appoints Frederick Driscoll to Its Board of Directors - GlobeNewswire
Wed, May 11, 2016
4:30 PM Cynapsus Therapeutics Reports First Quarter 2016 Financial Results and Recent Developments - GlobeNewswire
4:15 PM Cynapsus Therapeutics Announces Results of AGM - GlobeNewswire
Thu, Apr 28, 2016
6:01 AM Cynapsus Therapeutics to Present at Several Upcoming Investor Conferences - GlobeNewswire
Fri, Apr 15, 2016
6:00 AM Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting - GlobeNewswire
6:00 AM Cynapsus Therapeutics Announces Data Presentations at the American Academy of Neurology Annual Meeting - Marketwired
More News for CTH:CA >>

Tags for Cynapsus Therapeutics Inc.

Research stocks or mutual funds related to Cynapsus Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to CTH:CA. The keywords below have been associated to CTH:CA by either user submission or electronic means.

Miscellaneous Intermediation (523910) Common Stock Venture Capital Companies (7125) Financial Services Financial